Merck’s Discounted Zocor Has Had “Negligible Impact,” Teva Says
The generic manufacturer has captured over 70% of the generic market for its four strengths of simvastatin.
The generic manufacturer has captured over 70% of the generic market for its four strengths of simvastatin.